SYNAGIS (palivizumab) | Parent & Caregiver Website
WebSYNAGIS is a prescription medication that is injected (50 mg and 100 mg) in certain children to help prevent serious lung disease caused by respiratory syncytial virus (RSV). You should know that SYNAGIS is used to prevent RSV, and not to treat children who already have RSV, including children:
Synagis Vaccine: Uses, Dosage, Side Effects - Drugs.com
WebDec 27, 2023 · Synagis is used to prevent lung disease caused by respiratory syncytial virus. Learn about side effects, interactions and indications.
Palivizumab - Wikipedia
WebPalivizumab, sold under the brand name Synagis, is a monoclonal antibody produced by recombinant DNA technology used to prevent severe disease caused by respiratory syncytial virus (RSV) infections. It is recommended for infants at high-risk for RSV due to conditions such as prematurity or other medical problems including heart or lung diseases.
Palivizumab Prophylaxis in Infants and Young Children at …
WebJun 26, 2023 · Palivizumab (Synagis, Sobi, Inc, United States), is a humanized mouse immunoglobulin G1 (IgG1 κ) monoclonal antibody produced by recombinant DNA technology.
Synagis: Package Insert - Drugs.com
WebMar 20, 2024 · Synagis is a respiratory syncytial virus (RSV) F protein inhibitor monoclonal antibody indicated for the prevention of serious lower respiratory tract disease caused by respiratory syncytial virus (RSV) in pediatric patients:
Synagis (Palivizumab) | Treatments | Patients & Families | UW Health
WebSynagis is a medicine called a monoclonal antibody. Monoclonal antibodies act like your body’s own immune system to help fight off infections. The effects of Synagis last for one month. What is Synagis used for? Synagis is used to prevent severe illness in your child from a virus called respiratory syncytial virus (RSV). What is RSV?
Synagis (palivizumab): Uses, Side Effects, FAQs & More - GoodRx
WebFeb 4, 2024 · Synagis (palivizumab) is an injection of monoclonal antibodies that can recognize the respiratory syncytial virus (RSV). If RSV enters the body, these antibodies can stop the virus from entering your cells and spreading. This means that RSV is less likely to cause serious lung problems.
Synagis Intramuscular: Uses, Side Effects, Interactions ... - WebMD
WebFind patient medical information for Synagis intramuscular on WebMD including its uses, side effects and safety, interactions, pictures, warnings and user ratings.
WebSynagis (SIN a jiss) is an important medicine that is used to lessen the chance of your child getting a serious viral lung infection called RSV (Respiratory Syncytial Virus). RSV is a respiratory virus that can cause very serious pneumonia in children at risk. Synagis only helps to prevent serious RSV infections.
Synagis | European Medicines Agency
WebSynagis is indicated for the prevention of serious lower-respiratory-tract disease requiring hospitalisation caused by respiratory syncytial virus (RSV) in children at high risk for RSV disease: children less than two years of age and with haemodynamically significant congenital heart disease.
Skip to content